Neurorehabilitation Devices Market By Products (Neurorobotics, Brain-Computer Interface, Wearable Devices, Noninvasive Stimulators), By Therapy Area (Stroke, Multiple Sclerosis, Parkinson’s Disease, Cerebral Palsy, Others - Brain And Spinal Cord Injury), And Segment Forecasts To 2024
The global neurorehabilitation devices market in 2015 was valued at USD 915.1 million and is estimated to reach USD 3.2 billion by 2024. Around 1 billion people are suffering from neurological disorders across the globe. These neurological disorders are resulting in increased movement disabilities. The increasing prevalence of movement disability, attributed to various neurological disorders (multiple sclerosis, stroke, etc) along with need for comprehensive management is the key factors driving the market growth.
Every year around 15 million people suffer from stroke globally, of which 5 million people are affected by permanent disability. Each year Multiple sclerosis and Parkinson’s disease affect 2.5 million and 10 million patients respectively worldwide. The increasing prevalence and incidence rates of neurological disorders create a huge demand for neurorehab devices, as they ensure simplification of routine tasks for the disabled patients by reducing their dependency on others.
Furthermore, the rising awareness of neurorehab services among the care providers is contributing to the increasing adoption of these devices. In addition, consistent technological advancements are leading to introduction and commercialization of novel products in this sector. Majority of the manufacturers and distributors of neurorehab platforms are headquartered in North America region. North America dominates the market followed by Europe attributed to the rising awareness and increased adoption of novel technologies in these regions. Asia Pacific is growing at the highest CAGR among all the regions due to increasing target population and improving healthcare infrastructure.
Despite fluctuating economic conditions across different geographical regions coupled with the respective regulatory pressures, the companies offering neurorehab devices and services are exhibiting adaptability and efficacy. Some of the key market players are Bioness, Inc., Ectron Ltd., Hocoma AG, Medtronic, and Tyromotion. Collaborations for novel product development and strengthening of distribution networks constitute some of the strategic initiatives implemented by key players. For instance, Ectron Ltd. has collaborated with Bioness, Inc. and Tyromotion for distribution of their products across different geographical regions.
Further Key Findings from the Study Suggest:
Neurorobotics is expected to be one of the most lucrative segments in the coming years owing to the high availability of exoskeletons and prosthetics targeted for treating movement disabilities. Bioness, Inc. and Hocoma AG are few of the key manufacturers of exoskeletons and prosthetics.
Consistent technological sophistications in brain stimulations and machine learning brain-computer interface segment is expected to develop tremendously.
Non invasive stimulators have the potential to modulate brain plasticity. In February 2016, USFDA approved Medtronic’s brain stimulation therapy in the treatment of Parkinson’s disease.
Every year around 15 million people suffer from stroke globally, of which 5 million people are affected by permanent disability. Each year Multiple sclerosis and Parkinson’s disease affect 2.5 million and 10 million patients respectively worldwide. The increasing prevalence and incidence rates of neurological disorders create a huge demand for neurorehab devices, as they ensure simplification of routine tasks for the disabled patients by reducing their dependency on others.
Furthermore, the rising awareness of neurorehab services among the care providers is contributing to the increasing adoption of these devices. In addition, consistent technological advancements are leading to introduction and commercialization of novel products in this sector. Majority of the manufacturers and distributors of neurorehab platforms are headquartered in North America region. North America dominates the market followed by Europe attributed to the rising awareness and increased adoption of novel technologies in these regions. Asia Pacific is growing at the highest CAGR among all the regions due to increasing target population and improving healthcare infrastructure.
Despite fluctuating economic conditions across different geographical regions coupled with the respective regulatory pressures, the companies offering neurorehab devices and services are exhibiting adaptability and efficacy. Some of the key market players are Bioness, Inc., Ectron Ltd., Hocoma AG, Medtronic, and Tyromotion. Collaborations for novel product development and strengthening of distribution networks constitute some of the strategic initiatives implemented by key players. For instance, Ectron Ltd. has collaborated with Bioness, Inc. and Tyromotion for distribution of their products across different geographical regions.
Further Key Findings from the Study Suggest:
Neurorobotics is expected to be one of the most lucrative segments in the coming years owing to the high availability of exoskeletons and prosthetics targeted for treating movement disabilities. Bioness, Inc. and Hocoma AG are few of the key manufacturers of exoskeletons and prosthetics.
Consistent technological sophistications in brain stimulations and machine learning brain-computer interface segment is expected to develop tremendously.
Non invasive stimulators have the potential to modulate brain plasticity. In February 2016, USFDA approved Medtronic’s brain stimulation therapy in the treatment of Parkinson’s disease.
CHAPTER 1 RESEARCH METHODOLOGY & SCOPE
1.1 Region Wise Market Calculation
1.1.1 Region Wise Market: Base Estimates
1.1.2 Global Market: CAGR Calculation
1.2 Region based segment share calculation
1.3 List of Secondary Sources
CHAPTER 2 EXECUTIVE SUMMARY
CHAPTER 3 MARKET SNAPSHOT
CHAPTER 4 MARKET VARIABLES, TRENDS & SCOPE
4.1 Market segmentation & scope
4.1.1 Market Driver Analysis
4.1.1.1 Increasing prevalence and incidence rates of neurological disorders
4.1.1.2 Rise in geriatric population worldwide
4.1.1.3 Technological advancements
4.1.2 Market Restraint Analysis
4.1.2.1 Unavailability of personalized home care neurorehabilitation devices
4.1.2.2 Insufficient disposable income in developing countries
4.2 Penetration & growth prospect mapping
4.3 Neurorehabilitation Devices Market - SWOT Analysis, By Factor (political & legal, economic and technological)
4.4 Industry Analysis - Porter’s
CHAPTER 5 MARKET CATEGORIZATION 1: PRODUCT ESTIMATES & TREND ANALYSIS
5.1 Neurorehabilitation Devices market: Product movement analysis
5.2 Neurorobotics
5.2.1 Neurorobotics market estimates and forecasts, 2013 - 2024 (USD Million)
5.3 Brain-computer interface
5.3.1 Brain-computer interface market estimates and forecasts, 2013 - 2024 (USD Million)
5.4 Wearable devices
5.4.1 Wearable devices market estimates and forecasts, 2013 - 2024 (USD Million)
5.5 Non-invasive Stimulators
5.5.1 Non-invasive Stimulators market estimates and forecasts, 2013 - 2024 (USD Million)
CHAPTER 6 MARKET CATEGORIZATION 2: THERAPY AREA ESTIMATES & TREND ANALYSIS
6.1 Neurorehabilitation Devices market: Therapy Areas movement analysis
6.2 Stroke
6.2.1 Stroke marketestimates and forecasts, 2013 - 2024 (USD Million)
6.3 Multiple Sclerosis
6.3.1 Multiple Sclerosis market estimates and forecasts, 2013 - 2024 (USD Million)
6.4 Parkinson's Disease
6.4.1 Parkinson's Disease market estimates and forecasts, 2013 - 2024 (USD Million)
6.5 Cerebral Palsy
6.5.1 Cerebral Palsy market estimates and forecasts, 2013 - 2024 (USD Million)
6.6 Others
6.6.1 Others market estimates and forecasts, 2013 - 2024 (USD Million)
CHAPTER 7 MARKET CATEGORIZATION 3: REGIONAL ESTIMATES & TREND ANALYSIS, BY PRODUCT & THERAPY AREAS
9.1 Neurorehabilitation Devices market share by region, 2013 & 2024
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 UK
9.3.2 Germany
9.4 Asia Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.5 Latin America
9.5.1 Mexico
9.5.2 Brazil
9.6 MEA
9.6.1 South Africa
CHAPTER 10 COMPETITIVE LANDSCAPE
10.1 Strategy framework
10.2 Market participation categorization
10.3 Company Profiles
10.3.1 Biometrics Ltd
10.3.1.1 Company Overview
10.3.1.2 Financial Performance
10.3.1.3 Product Benchmarking
10.3.1.4 Strategic Initiatives
10.3.2 Bioness, Inc.
10.3.2.1 Company Overview
10.3.2.2 Financial Performance
10.3.2.3 Product Benchmarking
10.3.2.4 Strategic Initiatives
10.3.3 Bionik Laboratories Corp. (BNKL)
10.3.3.1 Company Overview
10.3.3.2 Financial Performance
10.3.3.3 Product Benchmarking
10.3.3.4 Strategic Initiatives
10.3.4 Bioxtreme Robotics Rehabilitation
10.3.4.1 Company Overview
10.3.4.2 Financial Performance
10.3.4.3 Product Benchmarking
10.3.4.4 Strategic Initiatives
10.3.5 Ectron Ltd
10.3.5.1 Company Overview
10.3.5.2 Financial Performance
10.3.5.3 Product Benchmarking
10.3.5.4 Strategic Initiatives
10.3.6 Ekso Bionics
10.3.6.1 Company Overview
10.3.6.2 Financial Performance
10.3.6.3 Product Benchmarking
10.3.6.4 Strategic Initiatives
10.3.7 Hocoma AG
10.3.7.1 Company Overview
10.3.7.2 Financial Performance
10.3.7.3 Product Benchmarking
10.3.7.4 Strategic Initiatives
10.3.8 Kinestica
10.3.8.1 Company Overview
10.3.8.2 Financial Performance
10.3.8.3 Product Benchmarking
10.3.8.4 Strategic Initiatives
10.3.9 Kinova Robotics
10.3.9.1 Company Overview
10.3.9.2 Financial Performance
10.3.9.3 Product Benchmarking
10.3.9.4 Strategic Initiatives
10.3.10 Medtronic PLC
10.3.10.1 Company Overview
10.3.10.2 Financial Performance
10.3.10.3 Product Benchmarking
10.3.10.4 Strategic Initiatives
10.3.11 NINET
10.3.11.1 Company Overview
10.3.11.2 Financial Performance
10.3.11.3 Product Benchmarking
10.3.11.4 Strategic Initiatives
10.3.12 Saebo Ltd
10.3.12.1 Company Overview
10.3.12.2 Financial Performance
10.3.12.3 Product Benchmarking
10.3.12.4 Strategic Initiatives
10.3.13 St. Jude Medical
10.3.13.1 Company Overview
10.3.13.2 Financial Performance
10.3.13.3 Product Benchmarking
10.3.13.4 Strategic Initiatives
10.3.14 Tyromotion
10.3.14.1 Company Overview
10.3.14.2 Financial Performance
10.3.14.3 Product Benchmarking
10.3.14.4 Strategic Initiatives
1.1 Region Wise Market Calculation
1.1.1 Region Wise Market: Base Estimates
1.1.2 Global Market: CAGR Calculation
1.2 Region based segment share calculation
1.3 List of Secondary Sources
CHAPTER 2 EXECUTIVE SUMMARY
CHAPTER 3 MARKET SNAPSHOT
CHAPTER 4 MARKET VARIABLES, TRENDS & SCOPE
4.1 Market segmentation & scope
4.1.1 Market Driver Analysis
4.1.1.1 Increasing prevalence and incidence rates of neurological disorders
4.1.1.2 Rise in geriatric population worldwide
4.1.1.3 Technological advancements
4.1.2 Market Restraint Analysis
4.1.2.1 Unavailability of personalized home care neurorehabilitation devices
4.1.2.2 Insufficient disposable income in developing countries
4.2 Penetration & growth prospect mapping
4.3 Neurorehabilitation Devices Market - SWOT Analysis, By Factor (political & legal, economic and technological)
4.4 Industry Analysis - Porter’s
CHAPTER 5 MARKET CATEGORIZATION 1: PRODUCT ESTIMATES & TREND ANALYSIS
5.1 Neurorehabilitation Devices market: Product movement analysis
5.2 Neurorobotics
5.2.1 Neurorobotics market estimates and forecasts, 2013 - 2024 (USD Million)
5.3 Brain-computer interface
5.3.1 Brain-computer interface market estimates and forecasts, 2013 - 2024 (USD Million)
5.4 Wearable devices
5.4.1 Wearable devices market estimates and forecasts, 2013 - 2024 (USD Million)
5.5 Non-invasive Stimulators
5.5.1 Non-invasive Stimulators market estimates and forecasts, 2013 - 2024 (USD Million)
CHAPTER 6 MARKET CATEGORIZATION 2: THERAPY AREA ESTIMATES & TREND ANALYSIS
6.1 Neurorehabilitation Devices market: Therapy Areas movement analysis
6.2 Stroke
6.2.1 Stroke marketestimates and forecasts, 2013 - 2024 (USD Million)
6.3 Multiple Sclerosis
6.3.1 Multiple Sclerosis market estimates and forecasts, 2013 - 2024 (USD Million)
6.4 Parkinson's Disease
6.4.1 Parkinson's Disease market estimates and forecasts, 2013 - 2024 (USD Million)
6.5 Cerebral Palsy
6.5.1 Cerebral Palsy market estimates and forecasts, 2013 - 2024 (USD Million)
6.6 Others
6.6.1 Others market estimates and forecasts, 2013 - 2024 (USD Million)
CHAPTER 7 MARKET CATEGORIZATION 3: REGIONAL ESTIMATES & TREND ANALYSIS, BY PRODUCT & THERAPY AREAS
9.1 Neurorehabilitation Devices market share by region, 2013 & 2024
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 UK
9.3.2 Germany
9.4 Asia Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.5 Latin America
9.5.1 Mexico
9.5.2 Brazil
9.6 MEA
9.6.1 South Africa
CHAPTER 10 COMPETITIVE LANDSCAPE
10.1 Strategy framework
10.2 Market participation categorization
10.3 Company Profiles
10.3.1 Biometrics Ltd
10.3.1.1 Company Overview
10.3.1.2 Financial Performance
10.3.1.3 Product Benchmarking
10.3.1.4 Strategic Initiatives
10.3.2 Bioness, Inc.
10.3.2.1 Company Overview
10.3.2.2 Financial Performance
10.3.2.3 Product Benchmarking
10.3.2.4 Strategic Initiatives
10.3.3 Bionik Laboratories Corp. (BNKL)
10.3.3.1 Company Overview
10.3.3.2 Financial Performance
10.3.3.3 Product Benchmarking
10.3.3.4 Strategic Initiatives
10.3.4 Bioxtreme Robotics Rehabilitation
10.3.4.1 Company Overview
10.3.4.2 Financial Performance
10.3.4.3 Product Benchmarking
10.3.4.4 Strategic Initiatives
10.3.5 Ectron Ltd
10.3.5.1 Company Overview
10.3.5.2 Financial Performance
10.3.5.3 Product Benchmarking
10.3.5.4 Strategic Initiatives
10.3.6 Ekso Bionics
10.3.6.1 Company Overview
10.3.6.2 Financial Performance
10.3.6.3 Product Benchmarking
10.3.6.4 Strategic Initiatives
10.3.7 Hocoma AG
10.3.7.1 Company Overview
10.3.7.2 Financial Performance
10.3.7.3 Product Benchmarking
10.3.7.4 Strategic Initiatives
10.3.8 Kinestica
10.3.8.1 Company Overview
10.3.8.2 Financial Performance
10.3.8.3 Product Benchmarking
10.3.8.4 Strategic Initiatives
10.3.9 Kinova Robotics
10.3.9.1 Company Overview
10.3.9.2 Financial Performance
10.3.9.3 Product Benchmarking
10.3.9.4 Strategic Initiatives
10.3.10 Medtronic PLC
10.3.10.1 Company Overview
10.3.10.2 Financial Performance
10.3.10.3 Product Benchmarking
10.3.10.4 Strategic Initiatives
10.3.11 NINET
10.3.11.1 Company Overview
10.3.11.2 Financial Performance
10.3.11.3 Product Benchmarking
10.3.11.4 Strategic Initiatives
10.3.12 Saebo Ltd
10.3.12.1 Company Overview
10.3.12.2 Financial Performance
10.3.12.3 Product Benchmarking
10.3.12.4 Strategic Initiatives
10.3.13 St. Jude Medical
10.3.13.1 Company Overview
10.3.13.2 Financial Performance
10.3.13.3 Product Benchmarking
10.3.13.4 Strategic Initiatives
10.3.14 Tyromotion
10.3.14.1 Company Overview
10.3.14.2 Financial Performance
10.3.14.3 Product Benchmarking
10.3.14.4 Strategic Initiatives
LIST OF TABLES
TABLE 1 Country share estimation
TABLE 2 North America neurorehabilitation devices market, by product, 2013 - 2024 (USD Million)
TABLE 3 North America neurorehabilitation devices market, by therapy areas, 2013 - 2024 (USD Million)
TABLE 4 U.S. neurorehabilitation devices market, by product, 2013 - 2024 (USD Million)
TABLE 5 U.S. neurorehabilitation devices market, by therapy areas, 2013 - 2024 (USD Million)
TABLE 6 Canada neurorehabilitation devices market, by product, 2013 - 2024 (USD Million)
TABLE 7 Canada neurorehabilitation devices market, by therapy areas, 2013 - 2024 (USD Million)
TABLE 8 Europe neurorehabilitation devices market, by product, 2013 - 2024 (USD Million)
TABLE 9 Europe neurorehabilitation devices market, by therapy areas, 2013 - 2024 (USD Million)
TABLE 10 UK neurorehabilitation devices market, by product, 2013 - 2024 (USD Million)
TABLE 11 UK neurorehabilitation devices market, by therapy areas, 2013 - 2024 (USD Million)
TABLE 12 Germany neurorehabilitation devices market, by product, 2013 - 2024 (USD Million)
TABLE 13 Germany neurorehabilitation devices market, by therapy areas, 2013 - 2024 (USD Million)
TABLE 14 Asia Pacific neurorehabilitation devices market, by product, 2013 - 2024 (USD Million)
TABLE 15 Asia Pacific neurorehabilitation devices market, by therapy areas, 2013 - 2024 (USD Million)
TABLE 16 Japan neurorehabilitation devices market, by product, 2013 - 2024 (USD Million)
TABLE 17 Japan neurorehabilitation devices market, by therapy areas, 2013 - 2024 (USD Million)
TABLE 18 China neurorehabilitation devices market, by product, 2013 - 2024 (USD Million)
TABLE 19 China neurorehabilitation devices market, by therapy areas, 2013 - 2024 (USD Million)
TABLE 20 India neurorehabilitation devices market, by product, 2013 - 2024 (USD Million)
TABLE 21 India neurorehabilitation devices market, by therapy areas, 2013 - 2024 (USD Million)
TABLE 22 Latin America neurorehabilitation devices market, by product, 2013 - 2024 (USD Million)
TABLE 23 Latin America neurorehabilitation devices market, by therapy areas, 2013 - 2024 (USD Million)
TABLE 24 Mexico neurorehabilitation devices market, by product, 2013 - 2024 (USD Million)
TABLE 25 Mexico neurorehabilitation devices market, by therapy areas, 2013 - 2024 (USD Million)
TABLE 26 Brazil neurorehabilitation devices market, by product, 2013 - 2024 (USD Million)
TABLE 27 Brazil neurorehabilitation devices market, by therapy areas, 2013 - 2024 (USD Million)
TABLE 28 MEA neurorehabilitation devices market, by product, 2013 - 2024 (USD Million)
TABLE 29 MEA neurorehabilitation devices market, by therapy areas, 2013 - 2024 (USD Million)
TABLE 30 South Africa neurorehabilitation devices market, by product, 2013 - 2024 (USD Million)
TABLE 31 South Africa neurorehabilitation devices market, by therapy areas, 2013 - 2024 (USD Million)
TABLE 1 Country share estimation
TABLE 2 North America neurorehabilitation devices market, by product, 2013 - 2024 (USD Million)
TABLE 3 North America neurorehabilitation devices market, by therapy areas, 2013 - 2024 (USD Million)
TABLE 4 U.S. neurorehabilitation devices market, by product, 2013 - 2024 (USD Million)
TABLE 5 U.S. neurorehabilitation devices market, by therapy areas, 2013 - 2024 (USD Million)
TABLE 6 Canada neurorehabilitation devices market, by product, 2013 - 2024 (USD Million)
TABLE 7 Canada neurorehabilitation devices market, by therapy areas, 2013 - 2024 (USD Million)
TABLE 8 Europe neurorehabilitation devices market, by product, 2013 - 2024 (USD Million)
TABLE 9 Europe neurorehabilitation devices market, by therapy areas, 2013 - 2024 (USD Million)
TABLE 10 UK neurorehabilitation devices market, by product, 2013 - 2024 (USD Million)
TABLE 11 UK neurorehabilitation devices market, by therapy areas, 2013 - 2024 (USD Million)
TABLE 12 Germany neurorehabilitation devices market, by product, 2013 - 2024 (USD Million)
TABLE 13 Germany neurorehabilitation devices market, by therapy areas, 2013 - 2024 (USD Million)
TABLE 14 Asia Pacific neurorehabilitation devices market, by product, 2013 - 2024 (USD Million)
TABLE 15 Asia Pacific neurorehabilitation devices market, by therapy areas, 2013 - 2024 (USD Million)
TABLE 16 Japan neurorehabilitation devices market, by product, 2013 - 2024 (USD Million)
TABLE 17 Japan neurorehabilitation devices market, by therapy areas, 2013 - 2024 (USD Million)
TABLE 18 China neurorehabilitation devices market, by product, 2013 - 2024 (USD Million)
TABLE 19 China neurorehabilitation devices market, by therapy areas, 2013 - 2024 (USD Million)
TABLE 20 India neurorehabilitation devices market, by product, 2013 - 2024 (USD Million)
TABLE 21 India neurorehabilitation devices market, by therapy areas, 2013 - 2024 (USD Million)
TABLE 22 Latin America neurorehabilitation devices market, by product, 2013 - 2024 (USD Million)
TABLE 23 Latin America neurorehabilitation devices market, by therapy areas, 2013 - 2024 (USD Million)
TABLE 24 Mexico neurorehabilitation devices market, by product, 2013 - 2024 (USD Million)
TABLE 25 Mexico neurorehabilitation devices market, by therapy areas, 2013 - 2024 (USD Million)
TABLE 26 Brazil neurorehabilitation devices market, by product, 2013 - 2024 (USD Million)
TABLE 27 Brazil neurorehabilitation devices market, by therapy areas, 2013 - 2024 (USD Million)
TABLE 28 MEA neurorehabilitation devices market, by product, 2013 - 2024 (USD Million)
TABLE 29 MEA neurorehabilitation devices market, by therapy areas, 2013 - 2024 (USD Million)
TABLE 30 South Africa neurorehabilitation devices market, by product, 2013 - 2024 (USD Million)
TABLE 31 South Africa neurorehabilitation devices market, by therapy areas, 2013 - 2024 (USD Million)
LIST OF FIGURES
FIG. 1 Market summary
FIG. 2 Market trends & outlook
FIG. 3 Neurorehabilitation devices: Market Segmentation
FIG. 4 Market driver relevance analysis (Current & future impact)
FIG. 5 Market restraint analysis (Current & future impact)
FIG. 6 Penetration & growth prospect mapping
FIG. 7 SWOT Analysis, By Factor (political & legal, economic and technological)
FIG. 8 Neurorehabilitation devices Porter’s analysis
FIG. 9 Neurorehabilitation devices market product outlook key takeaways
FIG. 10 Neurorehabilitation devices market: product movement analysis
FIG. 11 Neurorobotics market, 2013 - 2024 (USD Million)
FIG. 12 Brain-computer interface market, 2013 - 2024 (USD Million)
FIG. 13 Wearable devices market, 2013 - 2024 (USD Million)
FIG. 14 Non-invasive stimulators market, 2013 - 2024 (USD Million)
FIG. 15 Neurorehabilitation devices market therapy areas outlook key takeaways
FIG. 16 Neurorehabilitation devices market: Therapy areas movement analysis
FIG. 17 Stroke market, 2013 - 2024 (USD Million)
FIG. 18 Multiple Sclerosis market, 2013 - 2024 (USD Million)
FIG. 19 Parkinson's disease market, 2013 - 2024 (USD Million)
FIG. 20 Cerebral Palsy market, 2013 - 2024 (USD Million)
FIG. 21 Global others market, 2013 - 2024 (USD Million)
FIG. 22 Regional market place: Key takeaways
FIG. 23 Regional outlook, 2015 & 2024
FIG. 24 Strategy framework
FIG. 25 Participant categorization
FIG. 1 Market summary
FIG. 2 Market trends & outlook
FIG. 3 Neurorehabilitation devices: Market Segmentation
FIG. 4 Market driver relevance analysis (Current & future impact)
FIG. 5 Market restraint analysis (Current & future impact)
FIG. 6 Penetration & growth prospect mapping
FIG. 7 SWOT Analysis, By Factor (political & legal, economic and technological)
FIG. 8 Neurorehabilitation devices Porter’s analysis
FIG. 9 Neurorehabilitation devices market product outlook key takeaways
FIG. 10 Neurorehabilitation devices market: product movement analysis
FIG. 11 Neurorobotics market, 2013 - 2024 (USD Million)
FIG. 12 Brain-computer interface market, 2013 - 2024 (USD Million)
FIG. 13 Wearable devices market, 2013 - 2024 (USD Million)
FIG. 14 Non-invasive stimulators market, 2013 - 2024 (USD Million)
FIG. 15 Neurorehabilitation devices market therapy areas outlook key takeaways
FIG. 16 Neurorehabilitation devices market: Therapy areas movement analysis
FIG. 17 Stroke market, 2013 - 2024 (USD Million)
FIG. 18 Multiple Sclerosis market, 2013 - 2024 (USD Million)
FIG. 19 Parkinson's disease market, 2013 - 2024 (USD Million)
FIG. 20 Cerebral Palsy market, 2013 - 2024 (USD Million)
FIG. 21 Global others market, 2013 - 2024 (USD Million)
FIG. 22 Regional market place: Key takeaways
FIG. 23 Regional outlook, 2015 & 2024
FIG. 24 Strategy framework
FIG. 25 Participant categorization
